Moving into the new Buffett Cancer Center at UNMC/Nebraska Medicine will be a clinical study led by Dr. Julie Vose, chief of hematology/oncology at Nebraska Medicine. She explains how this study shows the promise of a breakthrough in treatment lymphoma.